Related Experiment Video

Updated: May 31, 2026

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

Metastatic cutaneous squamous cell carcinoma responding to erlotinib therapy

Candace Engelhardt, Clara Curiel-Lewandrowski, James Warneke

    Journal of the American Academy of Dermatology
    |June 18, 2011
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
    06:51

    Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

    Published on: July 21, 2018

    Related Experiment Videos

    Last Updated: May 31, 2026

    Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
    09:38

    Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

    Published on: August 11, 2017

    Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
    06:51

    Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

    Published on: July 21, 2018

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...
    Skin Cancer01:30

    Skin Cancer

    Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
    Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

    Articles linked to this work by shared authors, journal, and citation graph.

    Single-Cell Transcriptomic Mapping of PD-L1/TLR4 Remodeling Informs Topical Immunoprevention Timing in Skin Carcinogenesis.

    bioRxiv : the preprint server for biology·2026

    CD70 drives cSCC growth by linking DNA damage response, inflammation, and tumor-stromal signaling.

    Cell death & disease·2026

    Correction: Melanoma toolkit for early detection for primary care clinicians: a 1-year follow-up on outcomes.

    Frontiers in medicine·2026

    CD70 drives cSCC growth by linking DNA damage response, inflammation, and tumor-stromal signaling.

    Research square·2026

    Management of multifocal and metastatic retroperitoneal sarcoma: an updated consensus approach from the transatlantic australasian retroperitoneal sarcoma working group (TARPSWG).

    Cancer treatment reviews·2026

    Towards a transcriptomic biomarker for the classification of melanocytic neoplasms.

    PLoS genetics·2025

    Cardiometabolic Associations of Dermatological Treatments. Part II: Targeted and Biologic Therapies.

    Journal of the American Academy of Dermatology·2026

    Cardiometabolic Associations of Dermatological Treatments. Part I: Systemic Therapies.

    Journal of the American Academy of Dermatology·2026

    Comorbidity-Guided Management of Pyoderma Gangrenosum: A Clinical Guide to Emerging Therapeutic Targets.

    Journal of the American Academy of Dermatology·2026

    Laser and Energy-Based Device Use in Skin of Color: A Clinical Review of Safety, Efficacy, and Best Practices.

    Journal of the American Academy of Dermatology·2026

    Elevated serum amyloid A levels are associated with rapidly progressive interstitial lung disease in dermatomyositis: a retrospective cohort study.

    Journal of the American Academy of Dermatology·2026

    Validation of the integrated 40-gene expression profile (i40-GEP) which provides prognostic and adjuvant radiation benefit for high-risk cutaneous squamous cell carcinoma.

    Journal of the American Academy of Dermatology·2026

    A marine-derived meroterpenoid inhibits colorectal cancer via PI3K pathway modulation in mice.

    Marine life science & technology·2026

    Noncoding RNA encoded peptides in tumors from discovery to mechanism and clinical translation.

    iScience·2026

    SGLT2 inhibitor therapy is associated with IL-10/TGF-α/sVEGFR3 signalling and adipose tissue remodelling in advanced heart failure.

    Journal of molecular and cellular cardiology plus·2026

    Efficacy and safety of SCT200 in patients with recurrent or metastatic head and neck squamous cell carcinoma after platinum failure: A phase 2 study.

    Cancer pathogenesis and therapy·2026

    Rapamycin Attenuates Acute Pancreatitis-Induced Acinar Injury in Mice With Pancreatic Loss of Gα13.

    Gastro hep advances·2026

    PTC124 promotes mutation site-dependent readthrough of STK11 nonsense mutations and restores tumor suppressor function.

    BBA advances·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us